Akari Therapeutics Plc Adr (AKTX)

Oct 25, 2025

What Wall Street predicts for Akari Therapeutics Plc Depositary Receipt stock priceMarket Performance Summary & Weekly Breakout Stock Alerts - newser.com

Oct 25, 2025

Oct 23, 2025

Akari Therapeutics appoints Kameel Farag as interim CFO - Investing.com India

Oct 23, 2025

Oct 23, 2025

Akari Therapeutics appoints Kameel Farag as interim CFO By Investing.com - Investing.com Philippines

Oct 23, 2025

Oct 22, 2025

Akari Therapeutics launches CEO Corner to enhance investor communications By Investing.com - Investing.com

Oct 22, 2025

Oct 16, 2025

Form 424B5 Akari Therapeutics Plc - StreetInsider

Oct 16, 2025

Oct 15, 2025

Akari Therapeutics stock falls after $2.5 million registered offering - Investing.com

Oct 15, 2025

Oct 15, 2025

Akari Therapeutics secures $2.5 million through registered offering - Investing.com India

Oct 15, 2025

Oct 15, 2025

$2.5M raise: Akari Therapeutics to issue 3,125,000 ADSs in registered direct offering - Stock Titan

Oct 15, 2025

Oct 09, 2025

Akari Therapeutics files new patents for cancer treatment technology - Investing.com India

Oct 09, 2025

Oct 09, 2025

Akari Therapeutics Files Two New Patents for Immuno-Oncology Mode of Action for Novel ADC Platform Utilizing Spliceosome Modulating Payload PH1 - Sahm

Oct 09, 2025

Oct 03, 2025

Morning Market Movers: DBVT, CLPT, DWTX, Seeing Big Swings - RTTNews

Oct 03, 2025

Oct 03, 2025

Will Akari Therapeutics Plc (Common Stock) (CLA) stock beat revenue estimatesWeekly Profit Analysis & Weekly Market Pulse Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Akari Therapeutics Announces Abstract Accepted for Oral Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting - Sahm

Oct 03, 2025

Sep 25, 2025

Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews

Sep 25, 2025

Sep 24, 2025

Akari’s ADC payload shows promise against resistant prostate cancer By Investing.com - Investing.com South Africa

Sep 24, 2025

Sep 24, 2025

Akari’s ADC payload shows promise against resistant prostate cancer - Investing.com India

Sep 24, 2025

Sep 24, 2025

First Potential Treatment for AR-V7 Driven Prostate Cancer: Akari's PH1 Shows Dual Action in Studies - Stock Titan

Sep 24, 2025

Sep 22, 2025

Can momentum traders help lift Tripadvisor Inc.2025 Pullback Review & Verified Momentum Watchlists - newser.com

Sep 22, 2025

Sep 19, 2025

Analyzing PRA Group Inc. with risk reward ratio chartsJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com

Sep 19, 2025

Sep 19, 2025

Institutional scanner results for ANSYS Inc.Entry Point & Verified Technical Trade Signals - newser.com

Sep 19, 2025

Sep 19, 2025

Does SRTY fit your quant trading modelPortfolio Gains Report & Stock Timing and Entry Methods - newser.com

Sep 19, 2025

Sep 17, 2025

Akari Therapeutics files patent for novel cancer treatment approach By Investing.com - Investing.com South Africa

Sep 17, 2025

Sep 17, 2025

Akari Therapeutics files patent for novel cancer treatment approach - Investing.com

Sep 17, 2025

Sep 17, 2025

Revolutionary Spliceosome Cancer Treatment: Akari Files Patent for First-in-Class ADC Platform Technology - Stock Titan

Sep 17, 2025

Sep 16, 2025

Is BSIIU stock reversal real or fake2025 Market Overview & Verified Swing Trading Watchlists - newser.com

Sep 16, 2025

Sep 14, 2025

Security Solutions Inc.2025 Market Outlook & Smart Money Movement Tracker - newser.com

Sep 14, 2025

Sep 14, 2025

Applying big data sentiment scoring on HLITJuly 2025 Recap & Free Technical Pattern Based Buy Signals - newser.com

Sep 14, 2025

Sep 05, 2025

Novel ADC Developer Akari Therapeutics to Showcase Pipeline at Major Healthcare Conference - Stock Titan

Sep 05, 2025

Sep 03, 2025

Next-Gen Cancer Drug Developer Akari Therapeutics Showcases Novel IO-Payload ADC Platform - Stock Titan

Sep 03, 2025

Aug 30, 2025

Advanced analytics toolkit walkthrough for Educational Development CorporationShare Buyback & Free Expert Approved Momentum Trade Ideas - Newser

Aug 30, 2025

Aug 29, 2025

What high frequency data says about MGTXOil Prices & Free Technical Confirmation Trade Alerts - Newser

Aug 29, 2025

Aug 28, 2025

Using AI based signals to follow BWXT2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser

Aug 28, 2025

Aug 28, 2025

Analyzing recovery setups for Guardian Pharmacy Services Inc. investorsMarket Volume Report & Weekly High Return Stock Forecasts - Newser

Aug 28, 2025

Aug 21, 2025

Akari Therapeutics completes $2.8 million note offering and extends warrant terms - Investing.com

Aug 21, 2025

Aug 19, 2025

Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan

Aug 19, 2025

Aug 14, 2025

Cancer Drug Developer Akari Therapeutics Showcases Pipeline at Webull Biotech Conference - Stock Titan

Aug 14, 2025

Aug 09, 2025

Is BACQR still worth holding after the dipEquity Market Return Forecast Model Update - Newser

Aug 09, 2025

Jul 31, 2025

Insider Stock Buying Reaches US$1.79m On Akari Therapeutics - Sahm

Jul 31, 2025

Jul 29, 2025

Akari Therapeutics Reveals Breakthrough Progress in Cancer-Fighting Drug Development - Stock Titan

Jul 29, 2025

Jul 23, 2025

Akari Therapeutics advances cancer-fighting ADC technology with PH1 payload - Investing.com India

Jul 23, 2025

Jul 23, 2025

Revolutionary Cancer Drug PH1 Targets KRAS, BRAF While Activating Immune System Against Tumors - Stock Titan

Jul 23, 2025

Jul 22, 2025

Akari Therapeutics CEO Shares Exclusive Insights on Next-Gen Cancer Drug Development Strategy - Stock Titan

Jul 22, 2025

Jul 11, 2025

INKT Stock Quote Price and Forecast - CNN

Jul 11, 2025

Jul 01, 2025

Akari Therapeutics shareholders approve equity plan increase and director elections - Investing.com

Jul 01, 2025

Jun 25, 2025

Akari Therapeutics Expands Global IP Portfolio: Key Patent Win for Cancer Drug Platform in India - Stock Titan

Jun 25, 2025

Jun 24, 2025

AKTX CEO buys 10,000 ADS at $1.20 in Form 4 insider filing - Stock Titan

Jun 24, 2025

Jun 18, 2025

Akari Therapeutics secures Indian patent for cancer drug payload - Investing.com India

Jun 18, 2025

Jun 18, 2025

Akari's Revolutionary Cancer Drug Technology Wins Key Patent in India's 2.08M Patient Market - Stock Titan

Jun 18, 2025

May 29, 2025

Akari Therapeutics Releases “Meet the Team” Video Featuring Recently Appointed Mark F. Kubik, Head of Business Development – Oncology - Sahm

May 29, 2025

May 22, 2025

Akari Therapeutics CEO Reveals Latest Oncology ADC Developments at Major Webull Investor Event - Stock Titan

May 22, 2025

May 17, 2025

Akari Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 17, 2025

May 01, 2025

Akari Therapeutics appoints new head of oncology business By Investing.com - Investing.com India

May 01, 2025

May 01, 2025

Akari Therapeutics appoints new head of oncology business - Investing.com

May 01, 2025

Apr 22, 2025

Akari Therapeutics' New CEO Reveals Future Roadmap: Key Insights from First Leadership Address - Stock Titan

Apr 22, 2025

Apr 17, 2025

Akari Therapeutics Advances ADC Development Amid Financial Challenges - TipRanks

Apr 17, 2025

Apr 16, 2025

Akari Therapeutics Transforms: Next-Gen Cancer Drug Shows Promise Amid 2024 Results - Stock Titan

Apr 16, 2025